poly(3,4-dihydroxyphenylalanine)

Also Known As:

poly(3,4-dihydroxy-L-phenylalanine); poly(DOPA); poly(L-DOPA)

Networked: 5 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Catecholamines: 15682
    - Dihydroxyphenylalanine: 1494
      - poly(3,4-dihydroxyphenylalanine): 5
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Catecholamines: 15682
        Dihydroxyphenylalanine: 1494
        poly(3,4-dihydroxyphenylalanine): 5
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Tyrosine: 10509
        Dihydroxyphenylalanine: 1494
        poly(3,4-dihydroxyphenylalanine): 5
      - Phenylalanine: 4090
        Dihydroxyphenylalanine: 1494
        poly(3,4-dihydroxyphenylalanine): 5
Macromolecular Substances: 97
- Polymers: 13051
  - poly(3,4-dihydroxyphenylalanine): 5
Biomedical and Dental Materials
- Polymers: 13051
  - poly(3,4-dihydroxyphenylalanine): 5
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - poly(3,4-dihydroxyphenylalanine): 5

Experts

1.	Hashemi-Moghaddam, Hamid: 1 article (01/2021)
2.	Larijani, Kambiz: 1 article (01/2021)
3.	Madanchi, Hamid: 1 article (01/2021)
4.	Mirjafary, Zohreh: 1 article (01/2021)
5.	Mirzababaei, Mahdi: 1 article (01/2021)
6.	Baskaran, Rengarajan: 1 article (10/2020)
7.	Davaa, Enkhzaya: 1 article (10/2020)
8.	Kang, Sumin: 1 article (10/2020)
9.	Kim, Jung Joo: 1 article (10/2020)
10.	Ozlu, Busra: 1 article (10/2020)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/01/2020 - "STATEMENT OF SIGNIFICANCE: In this study, we proposed a therapeutic approach for the effective treatment of Parkinson's disease (PD) using newly designed poly(l-DOPA)-based self-assembled nanodrug (NanoDOPA) prepared from amphiphilic block copolymers possessing poly(l-DOPA(OAc)2), which is a precursor of l-DOPA as a hydrophobic segment, for treatment in a PD model mouse. "
2.	Neoplasms (Cancer) 10/14/2020 - "T1-Positive Mn2+-Doped Multi-Stimuli Responsive poly(L-DOPA) Nanoparticles for Photothermal and Photodynamic Combination Cancer Therapy." 10/14/2020 - "In this study, we designed near-infrared (NIR)-responsive Mn2+-doped melanin-like poly(L-DOPA) nanoparticles (MNPs), which act as multifunctional nano-platforms for cancer therapy. " 01/01/2021 - "In this paper, NL2 peptide as a tumor targeted peptide was bonded on the surface of poly 3,4-Dihydroxy-L-phenylalanine (Poly L-DOPA) graphene quantum dots (GQD), which was imprinted by Doxorubicin (DOX). "
3.	Wounds and Injuries (Trauma) 01/01/2023 - "Solutions of gelatin modified with poly(l-DOPA) moieties (GelDOPA) are characterized by faster physical gelation and increased viscosity, providing better wound control on double-curved tissue surfaces compared to those of l-DOPA-conjugated gelatin. "
4.	Breast Neoplasms (Breast Cancer) 10/01/2023 - "Molecular imprinting of miR-559 on a peptide-immobilized poly L-DOPA/silica core-shell and in vitro investigating its effects on HER2-positive breast cancer cells."

Related Drugs and Biologics

1.	Levodopa (L Dopa)
2.	Melanins (Melanin)
3.	Peptides (Polypeptides)
4.	Silicon Dioxide (Silica)
5.	Graphite
6.	Gelatin
7.	Doxorubicin (Adriamycin)

Related Therapies and Procedures

1.	Therapeutics
2.	Quantum Dots (Quantum Dot)